Supriya Singh, V. Roja, Khushboo Garg, N. Sehrawat, Jyotika Bhatti, A. Chakma
{"title":"Homoeopathy in the management of chronic kidney disease – A narrative review","authors":"Supriya Singh, V. Roja, Khushboo Garg, N. Sehrawat, Jyotika Bhatti, A. Chakma","doi":"10.53945/2320-7094.1099","DOIUrl":null,"url":null,"abstract":"Background: Chronic kidney disease (CKD) is the third fastest-growing cause of death around the world and is projected to become the fifth most common cause of years of life lost worldwide by 2040. Objective: This review was done to explore the strengths of homoeopathy in the management of CKD through pre-clinical, clinical and anecdotal evidence. Methods: A search was made for homoeopathic management of CKD in PubMed, Central Council for Research in Homoeopathy e-library, AYUSH Research Portal, EMBASE and Google Scholar. The basic search terms included ‘Homoeopathy’ or ‘homoeopathic drugs’, ‘ESRD’, ‘CRF’, ‘CKD’ and ‘Bright’s disease’. No rigid inclusion criteria was kept due to the paucity of literature on this subject concerning homoeopathy; hence, all studies were included in this review. Further, literature review, through homoeopathic repertories, was also conducted for the anecdotal evidence of frequently used homoeopathic drugs used in the management of CKD. Results: Through an online search, 11 studies were found related to the subject which included two randomised controlled trials (RCTs), eight case series/case reports and one pre-clinical study. Two RCTs focussed on symptoms/signs due to CKD such as pruritus, asthenia, lethargy and headache with positive effects. The evidence generated through case series/reports, though useful for hypothesis-generating studies, was found to have poor reporting quality. Conclusion: At present, the available evidence towards the benefits of homoeopathy in CKD is weak. Further well-designed studies are warranted. Acknowledgments and Source of Funding No finances were involved for this review.","PeriodicalId":13469,"journal":{"name":"Indian Journal of Research in Homoeopathy","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Research in Homoeopathy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53945/2320-7094.1099","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 3
Abstract
Background: Chronic kidney disease (CKD) is the third fastest-growing cause of death around the world and is projected to become the fifth most common cause of years of life lost worldwide by 2040. Objective: This review was done to explore the strengths of homoeopathy in the management of CKD through pre-clinical, clinical and anecdotal evidence. Methods: A search was made for homoeopathic management of CKD in PubMed, Central Council for Research in Homoeopathy e-library, AYUSH Research Portal, EMBASE and Google Scholar. The basic search terms included ‘Homoeopathy’ or ‘homoeopathic drugs’, ‘ESRD’, ‘CRF’, ‘CKD’ and ‘Bright’s disease’. No rigid inclusion criteria was kept due to the paucity of literature on this subject concerning homoeopathy; hence, all studies were included in this review. Further, literature review, through homoeopathic repertories, was also conducted for the anecdotal evidence of frequently used homoeopathic drugs used in the management of CKD. Results: Through an online search, 11 studies were found related to the subject which included two randomised controlled trials (RCTs), eight case series/case reports and one pre-clinical study. Two RCTs focussed on symptoms/signs due to CKD such as pruritus, asthenia, lethargy and headache with positive effects. The evidence generated through case series/reports, though useful for hypothesis-generating studies, was found to have poor reporting quality. Conclusion: At present, the available evidence towards the benefits of homoeopathy in CKD is weak. Further well-designed studies are warranted. Acknowledgments and Source of Funding No finances were involved for this review.
背景:慢性肾脏疾病(CKD)是全球第三大增长最快的死亡原因,预计到2040年将成为全球第五大最常见的生命损失原因。目的:本综述通过临床前、临床和轶事证据探讨顺势疗法在CKD治疗中的优势。方法:在PubMed、Central Council for Research in顺势疗法电子图书馆、AYUSH Research Portal、EMBASE和谷歌Scholar中检索顺势疗法治疗CKD的相关文献。基本搜索词包括“顺势疗法”或“顺势疗法药物”、“ESRD”、“CRF”、“CKD”和“布莱特氏病”。由于缺乏关于顺势疗法的文献,没有严格的纳入标准;因此,本综述纳入了所有研究。此外,通过顺势疗法的文献回顾,也对经常使用的顺势疗法药物用于CKD管理的轶事证据进行了回顾。结果:通过在线搜索,发现了11项与该主题相关的研究,其中包括2项随机对照试验(rct), 8个病例系列/病例报告和1项临床前研究。两项随机对照试验关注慢性肾病引起的症状/体征,如瘙痒、虚弱、嗜睡和头痛,均有积极作用。通过病例系列/报告产生的证据,虽然对产生假设的研究有用,但发现报告质量较差。结论:目前,顺势疗法治疗CKD的疗效证据不足。进一步精心设计的研究是有必要的。致谢和资金来源本综述不涉及财务。